Skip to content

Insider · CIK 0001647805

Frank Torti

presidentchairofficerdirector

Files at ROIV (Roivant Sciences Ltd.), IMVT (Immunovant, Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 30, 2026ROIV
Roivant Sciences Ltd.
FTax withholding
Common Shares
+40,309$36.57$1.5M13,495,89310 d ago
Dec 23, 2025ROIV
Roivant Sciences Ltd.
AGrant or award
Common Shares
+175,380$22.45$3.9M13,911,927Dec 29, 2025
Dec 24, 2025ROIV
Roivant Sciences Ltd.
JOther
Common Shares
-64,891$22.47$1.5M13,847,036Dec 29, 2025
Dec 24, 2025ROIV
Roivant Sciences Ltd.
GGift
Common Shares
-110,489$0.00$013,736,547Dec 29, 2025
Jul 30, 2025ROIV
Roivant Sciences Ltd.
AGrant or award
Common Shares
+1,836,547$0.00$01,836,547Aug 1, 2025
Jul 30, 2025ROIV
Roivant Sciences Ltd.
AGrant or award
Common Shares
+11,900,000$0.00$013,736,547Aug 1, 2025
Apr 1, 2025IMVT
Immunovant, Inc.
AGrant or award
Common Stock
+199,365$0.00$0835,039Apr 3, 2025
Apr 1, 2025IMVT
Immunovant, Inc.
AGrant or award
Stock Option (right to buy)derivative
+93,599$0.00$093,599Apr 3, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Frank Torti: insider trades and track record | InsiderTell